Limited Edition Golden Llama is here! Check out how you can get one. 
Limited Edition Golden Llama is here! Check out how you can get one.
Offering SPR-BLI Services - Proteins provided for free! Offering SPR-BLI Services - Proteins provided for free!
Here come GMP Grade Cytokines！Free Sample is available！ Here come GMP Grade Cytokines！Free Sample is available！
| 제품번호 | 종 | 제품 설명 | 구조 | 순도 | 특징 |
|---|---|---|---|---|---|
| FKA-H5122 | Human | Human FKBP12 / FKBP1A Protein, His Tag |  |
|
| Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
|---|---|---|---|---|---|---|---|---|---|---|
| Tacrolimus Hydrate | MR-4; RTU-007; LCP-Tacro; FR-900506; L-679934; FK-506MR; FK-506E; FK-506 | Approved | Astellas Pharma Inc | Protopy, Graceptor (as hydrate), Protopic, Prograf (as hydrate), Hecoria (as hydrate), Hexal, Envarsus XR, Talymus, 普乐可复, Advagraf, Envarsus, Modigraf, Astagraf XL, TacroBell | Japan | Arthritis, Rheumatoid; Colitis, Ulcerative; Conjunctivitis, Allergic; Lupus Nephritis; Coronary Restenosis; Dermatitis, Atopic; Rejection of organ transplantation; Myasthenia Gravis | Astellas Pharma Inc | 1993-01-01 | Wounds and Injuries; Brain Death; Conjunctivitis, Allergic; Psoriasis; Amputation, Traumatic; Pulmonary Arterial Hypertension; Colitis, Ulcerative; Asthma; Surgical Wound Infection; Burns; Rejection in heart transplantation; Infertility, Female; Conjunctivitis; Nephrotic Syndrome; Coronary Restenosis; Renal Insufficiency, Chronic; Keratoconjunctivitis; Dermatitis, Atopic; Peripheral Nerve Injuries; Ocular inflammation; Encephalitis; Edema; Vitiligo; Crohn Disease; Primary Graft Dysfunction; Myasthenia Gravis; Polymyositis; Keratoconjunctivitis Sicca; Liver Failure; Reperfusion Injury; Genital Diseases, Male; Medication Adherence; Bone marrow transplant rejection; Rejection of liver transplantation; Glomerulonephritis, IGA; Dermatomyositis; Rejection of renal transplantation; Keratoplasty rejection; Rejection of lung transplantation; Renal Insufficiency; Arthritis, Rheumatoid; Kidney Diseases; Graft vs Host Disease; Lupus Erythematosus, Cutaneous; Lupus Nephritis; Rejection of organ transplantation; Dry Eye S | Details |
| Tacrolimus Hydrate | MR-4; RTU-007; LCP-Tacro; FR-900506; L-679934; FK-506MR; FK-506E; FK-506 | Approved | Astellas Pharma Inc | Protopy, Graceptor (as hydrate), Protopic, Prograf (as hydrate), Hecoria (as hydrate), Hexal, Envarsus XR, Talymus, 普乐可复, Advagraf, Envarsus, Modigraf, Astagraf XL, TacroBell | Japan | Arthritis, Rheumatoid; Colitis, Ulcerative; Conjunctivitis, Allergic; Lupus Nephritis; Coronary Restenosis; Dermatitis, Atopic; Rejection of organ transplantation; Myasthenia Gravis | Astellas Pharma Inc | 1993-01-01 | Wounds and Injuries; Brain Death; Conjunctivitis, Allergic; Psoriasis; Amputation, Traumatic; Pulmonary Arterial Hypertension; Colitis, Ulcerative; Asthma; Surgical Wound Infection; Burns; Rejection in heart transplantation; Infertility, Female; Conjunctivitis; Nephrotic Syndrome; Coronary Restenosis; Renal Insufficiency, Chronic; Keratoconjunctivitis; Dermatitis, Atopic; Peripheral Nerve Injuries; Ocular inflammation; Encephalitis; Edema; Vitiligo; Crohn Disease; Primary Graft Dysfunction; Myasthenia Gravis; Polymyositis; Keratoconjunctivitis Sicca; Liver Failure; Reperfusion Injury; Genital Diseases, Male; Medication Adherence; Bone marrow transplant rejection; Rejection of liver transplantation; Glomerulonephritis, IGA; Dermatomyositis; Rejection of renal transplantation; Keratoplasty rejection; Rejection of lung transplantation; Renal Insufficiency; Arthritis, Rheumatoid; Kidney Diseases; Graft vs Host Disease; Lupus Erythematosus, Cutaneous; Lupus Nephritis; Rejection of organ transplantation; Dry Eye S | Details |
| Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
|---|---|---|---|---|---|
| Plerixafor/Tacrolimus Hydrate | MRG-001(MedRegen); AMD3100+FK506 | Phase 2 Clinical | MedRegen LLC | Coronavirus Disease 2019 (COVID-19); Respiratory Distress Syndrome, Adult; Abdominal Injuries; Wounds and Injuries | Details |
| Rimiducid | AP-1903 | Phase 2 Clinical | Ariad Pharmaceuticals Inc, Bellicum Pharmaceuticals Inc | Neuroblastoma; Multiple Myeloma; Prostatic Neoplasms, Castration-Resistant; Uveal melanoma; Anemia, Aplastic; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Metabolic Diseases; Prostatic Neoplasms; Osteopetrosis; Osteosarcoma; Sarcoma; Blastic Plasmacytoid Dendritic Cell Neoplasm; Colorectal Neoplasms; Lymphoma, Non-Hodgkin; Lymphoma; Leukemia, Myeloid, Acute; Lymphohistiocytosis, Hemophagocytic; Anemia, Sickle Cell; Leukemia, Biphenotypic, Acute; Leukemia, Lymphocytic, Chronic, B-Cell; Congenital Bone Marrow Failure Syndromes; Melanoma; Thalassemia; Leukemia, Myelogenous, Chronic; Bone Marrow Neoplasms; Leukemia; Hematologic Neoplasms; Lymphoma, B-Cell; Neoplasm, Residual; Solid tumours; Immunoproliferative Disorders; Leukemia, Lymphoid; Lymphatic Diseases; Primary Immunodeficiency Diseases; Anemia, Diamond-Blackfan; Graft vs Host Disease; Leukemia, Myelomonocytic, Chronic; Myelodysplastic Syndromes; Myeloproliferative Disorders; Hemoglobinopathies; Fanconi Anemia; Neoplasms; Immune System Diseases | Details |
| Plerixafor/Tacrolimus Hydrate | MRG-001(MedRegen); AMD3100+FK506 | Phase 2 Clinical | MedRegen LLC | Coronavirus Disease 2019 (COVID-19); Respiratory Distress Syndrome, Adult; Abdominal Injuries; Wounds and Injuries | Details |
| Rimiducid | AP-1903 | Phase 2 Clinical | Ariad Pharmaceuticals Inc, Bellicum Pharmaceuticals Inc | Neuroblastoma; Multiple Myeloma; Prostatic Neoplasms, Castration-Resistant; Uveal melanoma; Anemia, Aplastic; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Metabolic Diseases; Prostatic Neoplasms; Osteopetrosis; Osteosarcoma; Sarcoma; Blastic Plasmacytoid Dendritic Cell Neoplasm; Colorectal Neoplasms; Lymphoma, Non-Hodgkin; Lymphoma; Leukemia, Myeloid, Acute; Lymphohistiocytosis, Hemophagocytic; Anemia, Sickle Cell; Leukemia, Biphenotypic, Acute; Leukemia, Lymphocytic, Chronic, B-Cell; Congenital Bone Marrow Failure Syndromes; Melanoma; Thalassemia; Leukemia, Myelogenous, Chronic; Bone Marrow Neoplasms; Leukemia; Hematologic Neoplasms; Lymphoma, B-Cell; Neoplasm, Residual; Solid tumours; Immunoproliferative Disorders; Leukemia, Lymphoid; Lymphatic Diseases; Primary Immunodeficiency Diseases; Anemia, Diamond-Blackfan; Graft vs Host Disease; Leukemia, Myelomonocytic, Chronic; Myelodysplastic Syndromes; Myeloproliferative Disorders; Hemoglobinopathies; Fanconi Anemia; Neoplasms; Immune System Diseases | Details |
This web search service is supported by Google Inc.
A-Z
